How Irish Women in Their Fifties Are Beating the TikTok Age Filter in Four Weeks.
Volunteer Four of the trial. Forty-six years old. Day zero, left. Day twenty-eight, right. Same window, same iPhone, same algorithm. The only thing that changed was a forty-four euro jar of eye cream applied twice a day.
A consultant dermatologist in Ranelagh rang me on a Tuesday in November about a TikTok filter that was sending her patients to her clinic in tears. Three months later, after a controlled experiment, two off-record industry sources, and twenty-eight days of testing on four volunteers, I have an answer that should change how every woman over forty-five buys skincare in this country.
Dr. Méabh O'Connor rang me on a Tuesday afternoon in November at twenty-past four. She does not normally ring journalists during clinic hours. She had pushed her four o'clock appointment back to twenty-past so that she could make the call before her last patient of the day.
She told me that she had a story she thought I should investigate. She told me that she did not want to be the one writing about it. She told me that she had been sitting on it for ten days and had concluded she could no longer not do something about it.
I want to tell you exactly what she said to me that afternoon, because the call is the spine of everything that follows in this piece.
In the previous fortnight, Dr. O'Connor had seen four patients arrive at her consulting rooms in Ranelagh in tears. Each of them, in different appointments on different days, had pulled her phone out of her handbag at the start of the consultation and shown the same thing. A screenshot from her camera roll. A photograph of herself, taken at home in the last week, with an age estimate overlaid on her face in large white type.
All four patients were between forty-four and fifty-three years old. All four had used a recently viral TikTok filter that uses face-recognition software to estimate the user's age from a single photograph. All four had been read by the algorithm as ten to fifteen years older than they actually were.
"They are not coming to me about wrinkles anymore," Dr. O'Connor said. "They are coming to me about the photograph the algorithm gave them. The pattern is too consistent for four patients in a fortnight to be coincidence. Something specific is being read."
She asked me if I would investigate it. I asked her to send me the screenshots, fully anonymised. She did so within the hour.
I sat at my kitchen table at half past ten that night and looked at the four photographs side by side. Each of the four women in the screenshots looked like a normal woman having a normal week. None of them looked dramatically older than her actual age in any human sense. And the filter, in each of the four cases, had condemned her by a decade.
I sent Méabh a text at twenty past eleven. I told her I would take it seriously. I told her I would run a proper experiment. I told her I would publish if there was anything publishable.
Three months later, this is what I have to publish.
Why I took the call seriously.
I should briefly say why I picked this up rather than letting it sit.
Six weeks before Dr. O'Connor's call, I had published a long investigation in these pages about eye-area skincare and the gap between what the beauty industry sells and what actually works. After that piece appeared, my inbox filled up with reader letters. The most common single question, asked by women aged forty-two through fifty-eight from every corner of the country, was a version of the same one.
"Why do I look so tired in photographs even when I feel rested? Why does my driver's licence photo look like a different person? Why has nobody in the beauty industry told me what to do about my eyes specifically, when everybody can see what is happening to them?"
Dr. O'Connor's call was the second confirmation, from a clinical setting, of a phenomenon I was already half-seeing in my inbox. Reader letters told me there was something women were experiencing about their faces that they did not have the vocabulary for. Dr. O'Connor told me that a piece of consumer technology, designed for a completely different purpose, had accidentally given them the vocabulary.
I took the call seriously because I was already half-convinced before she made it.
The experiment.
The first thing I did, the week after Méabh's call, was set up a controlled test. I will tell you how, because the methodology matters and because everything that follows in this piece depends on the data being clean.
I recruited fifteen Irish women between the ages of thirty-eight and sixty. I found them through my own contacts and through quiet asks in two private WhatsApp groups, deliberately spanning the age range. I photographed each of them in the same north-facing window of my flat in Dublin 8, at the same time of day, on the same iPhone, with the same version of the filter installed. Each woman was photographed once. Each was given her result. Each consented to the result being published anonymously.
The controlled test, third weekend of November. Fifteen Irish women. Same window. Same iPhone. Same filter.
What follows is a summary of the results, by volunteer code and age band. The full data set is on file with my editor.
The pattern was unmistakable and emerged immediately. Below the age of forty-four, the algorithm was accurate to within two or three years. From forty-four upwards, the deviation jumped sharply and stayed there. Every single woman aged forty-four and above was read by the filter as eight to fourteen years older than her actual age. The deviation never, in any of the fifteen results, ran in the other direction.
The volunteers themselves were divided in their reactions. Two of them laughed. Two of them cried. Most of them sat with the result for a moment, said something self-deprecating, and then asked me, quietly and a little urgently, what I thought it was reading.
I told them I had a hypothesis and I was going to test it.
Cover the wrinkles. Cover the eyes. Watch what happens.
With three of the volunteers, aged forty-six, forty-nine, and fifty-three, I ran a second test the following weekend. I am going to describe it step by step because what it shows is the entire point of this article.
Step one. Each volunteer covered her forehead wrinkles with her fingers, leaving the rest of her face visible. I ran the filter. Result, in all three cases: unchanged. The algorithm did not care about the forehead.
Step two. Each volunteer covered her smile lines, the creases between her nose and the corners of her mouth, with the side of her hand. I ran the filter. Result: unchanged. The algorithm did not care about the smile lines either.
Step three. Each volunteer covered her under-eye area with the pads of her thumbs, just below the lower lash line, leaving everything else exposed. I ran the filter. Result, in all three cases: the age estimate dropped by between nine and twelve years.
Every volunteer. Every time. Same camera. Same lighting. Same filter version.
It was not the wrinkles. It was the eyes.
The diagnostic isolation experiment with V4, second weekend of December. Same face, same camera, same algorithm. The only thing changing is what is visible to the lens.
The volunteer who showed the clearest result, a forty-nine-year-old hospital administrator from Limerick, sat back from the phone after the third test and said something that I am going to put in pull-quote because it became the spine of the rest of my reporting.
I have spent eight years and probably six thousand euro on anti-wrinkle products. I have never bought an eye cream in my adult life. I do not know how I missed this. Nobody in the beauty industry has ever told me to look at this part of my face. I have been pouring money into the wrong part of my own face for almost a decade.
Volunteer 5 · 49 · Limerick · December 2025
I had a hypothesis, three volunteers confirming it, and a piece of consumer software backing them up. What I did not yet have was a technical explanation for why the algorithm was doing what it was doing. So I went looking for one.
The engineer.
The face-recognition model that the filter is built on is owned and licensed by a major international technology company that I am not going to name because doing so would compromise my source. I will say only that the model is widely used and that you have almost certainly had your face processed through it in the last calendar year without thinking about it.
Through a contact who has worked in machine-learning research in Dublin's tech sector for many years, I was able to find and interview a former engineer who worked on the model itself for almost four years. He left the company in early 2024 and is now living in Berlin. We spoke over an encrypted video call. He talked to me on condition that he would not be named or otherwise identifiable. For the purposes of this article I am going to refer to him as Lukas.
Lukas had not seen Dr. O'Connor's screenshots. He had not seen my volunteer data. I described the pattern to him on the call. He nodded for almost the entire description.
"This is exactly what the model is designed to do," he said. "The model is doing its job. The fact that the women are upset about what it is telling them is not a model failure. It is a model success that the rest of the industry has been pretending is not real."
He explained the technical reasoning, slowly and patiently, in language I could understand. Machine-learning age-estimation models are trained on enormous data sets of human faces with known ages. The model finds, on its own, the regions of the face that produce the most reliable age signal. Across millions of examples, the same answer keeps coming back. The eye area is the most stable structural signal of biological age the human face produces. Forehead wrinkles are noisy because they are confounded by expression. Smile lines are noisy because they are confounded by recent emotion. The eye area, by contrast, is the cumulative record. It does not lie.
We knew which features the model was using. We could have told the beauty industry, at any point, that they were directing women's attention to the wrong part of their own faces. Nobody in the beauty industry asked us. Nobody in the beauty industry wanted to know. We are not the bad actors in this story.
"Lukas" · Former engineer · Now in Berlin · January 2026
I asked him whether he thought the pattern in my volunteer data was anomalous or normal. He laughed, gently, and told me my data was exactly what he would have predicted.
What the dermatologist said when I showed her the data.
I went back to Dr. O'Connor in late January with everything I had collected. The fifteen-volunteer results, the diagnostic isolation experiment, the conversation with Lukas. I wanted her to confirm from the medical side what the engineer had told me from the technical side.
She read the data set in about ten minutes. Then she sat back in her chair and said, almost wearily, that she had been waiting for somebody to ask her this question in print for fifteen years.
The skin around the eye, she told me, is structurally different to every other part of the face. It is approximately forty percent thinner than cheek skin. It has roughly half the sebaceous gland density. It has fewer Langerhans cells. It has significantly slower collagen turnover. Lymphatic drainage in the lower lid area is structurally inefficient by design, which is why fluid pools there overnight and stays pooled in women who are perimenopausal, dehydrated, or simply over forty-five.
All of this is well established in the dermatology literature. None of it is secret. Any consultant dermatologist working in private practice in this country could have told the beauty industry, decades ago, what the algorithm has now confirmed in cold quantitative terms.
"The eye area is the chronological record of the face," she said. "It shows time first, and it shows time most reliably. Humans intuit this, which is why we read tiredness in each other's faces before we read it anywhere else. Algorithms quantify it. The beauty industry pretends it isn't true because the beauty industry has not built itself around addressing it."
I asked her what an eye-area formulation actually needs to do, mechanically, to undo what the algorithm is reading. She gave me three answers and I will reproduce them here because they become the test against which everything that follows in this piece is measured.
It needs an active that stimulates collagen and elastin turnover without irritation, because the skin is too thin to tolerate the strength of active you would put on a cheek.
It needs genuine humectant capacity, because the violet shadow under the eye that the algorithm reads as age is partly hollowness and partly chronic dehydration of skin that has lost its capacity to retain water.
And it needs specific anti-inflammatory action on the lower lid, because the puffy bag that the algorithm is reading is mechanically a chronic small inflammatory event.
I asked her whether anything on the shelf in this country does all three at the concentrations that would actually work. She said three things did. I asked her to name them. She named them.
The chemist's verdict.
Before I went looking for any of the three products Dr. O'Connor had named, I went back to an off-record source of mine. She is a cosmetic chemist who has formulated for a luxury house whose name is on a navy box you have almost certainly seen. She spoke to me for my previous investigation and she agreed to speak again for this one. I sent her the data set, the engineer's testimony, and Dr. O'Connor's mechanism breakdown.
Her response, when she rang me back, was the angriest I have ever heard her on the phone.
I am going to put what she said in pull-quote because it is the sentence the entire piece pivots on, and because I want her to be on the record about it even though I cannot name her.
The industry has built itself around wrinkle products because wrinkle products are where the high margins live. Eye-area formulation is harder. The actives that work cost more. The skin is more sensitive so the failure rate in development is higher. The margins, in the end, are lower. We have always known what strangers read first. We have just been selling women what we wanted to sell them. The algorithm has now made it impossible to keep pretending.
Cosmetic chemist · Off-record · February 2026
I asked her, finally, the obvious question. If the industry has been quietly avoiding eye-area formulation for the reasons she had just listed, who has not been avoiding it? Who is actually formulating for this part of the face at concentrations that would do anything?
She gave me one name. It was one of the three names Dr. O'Connor had also given me.
The formulation.
I had one more source I wanted to check before I committed any of this to print. A senior floor manager I have known for years at one of Dublin's two large beauty halls. I have not named her in either of my previous investigations and I will not name her here. She has seen sales data across thirty years of luxury skincare. She knows what comes through the till and what comes back to the counter.
I sat with her over coffee on a Wednesday morning in early February and asked her, plainly, which eye-area formulation she now quietly recommends to her older clients when management is not listening.
She gave me the same name a third time.
The eye cream all three of my sources had independently named is called Lift & Brighten Peptide Eye Cream, and it is sold under the Gentle & Rose brand. It is formulated in Bulgaria by a small family-owned laboratory that I described in some detail in my previous investigation and that I am not going to re-describe here. The lab does not run advertising campaigns. It does not pay celebrities. It does not pay department store shelf fees.
I want to be straightforwardly honest about one thing in the product's name, because I made the same point in my previous piece and it remains relevant. The word "peptide" in the name is, in my view, slightly misleading. The active doing the heaviest work in the formulation is not a traditional peptide. It is bakuchiol, a plant-derived compound from the seeds of the Psoralea corylifolia, which acts on the same cellular-signalling pathway that peptides target, at concentrations the luxury houses do not approach.
Sitting behind the bakuchiol are the three things that make this specific formulation work on the part of the face the algorithm is reading. Pomegranate seed oil, which contains punicic acid, an omega-5 fatty acid with documented anti-inflammatory effect on lymphatic-stagnation skin. Sodium hyaluronate at cosmeceutical molecular weight, which holds water in the dermis where the violet shadow lives. And the Aquaxyl complex, a xylose-derived sugar humectant that triples the skin's natural moisture reservoir over a fortnight of use.
These are not the actives that anti-wrinkle face creams are built around. They are the actives that the eye area specifically needs, at concentrations the eye area specifically needs them at. Dr. O'Connor's three mechanistic requirements, point by point, are addressed by this single formulation.
The price for a single jar, when I checked the website at the end of February, was forty-four euro.
I want to put that against what Dr. O'Connor's two other recommendations would have cost the same buyer.
The third recommendation could be ordered from a Dublin kitchen table on a Thursday afternoon and would arrive in two working days. The other two could not.
The INCI document with bakuchiol marked in pencil. The active doing the work the algorithm is responding to.
Twenty-eight days. Four volunteers. One algorithm.
I went back to four of the original fifteen volunteers, all of whom had returned filter results in the ten-plus-year deviation range. They agreed to a twenty-eight-day product trial on the condition that they would be re-tested on the same filter, in the same window, on the same iPhone, at the end of it.
I want to be clear about the design of this part of the investigation, because the design is what makes the test honest. We were not measuring how the volunteers felt about their faces. We were not asking them to look in the mirror and tell me whether they looked better. We were not collecting subjective testimonials. We were measuring what an indifferent piece of consumer software, with no opinion about any of them, thought of their faces before they started using the product and what it thought of their faces twenty-eight days later. The only variable changing was the formulation on their lower lid, twice a day, for four weeks.
Each volunteer was asked to keep a brief daily journal of physical observations. Not feelings. Observations. Did the cream sting? No. Did the puffiness flatten? At what point in the day? Did make-up sit differently? At what week?
By day fourteen, three of the four volunteers were reporting visible reduction in lower-lid puffiness, observable in the morning before any make-up was applied. By day twenty-one, all four were. By day twenty-eight, two of the four had stopped wearing under-eye concealer entirely and reported being asked by colleagues whether they had been on holiday.
These are the subjective observations. They are not the point of this section. The point of this section is what happened when I ran the filter again.
Lift & Brighten Peptide Eye Cream. The jar each of the four volunteers used for the twenty-eight days.
What the filter said this time.
On the morning of day twenty-nine, the four volunteers returned to my flat in Dublin 8. Same north-facing window. Same iPhone. Same filter version. Same time of morning. No make-up on any of them. No filter, no edit, no second take.
One photograph each. Algorithm verdict, side by side with the day-zero result. I had not altered the lighting. I had not changed the camera. I had not retaken any photograph that returned a result I disliked. The only variable changed across the twenty-eight days was the formulation applied twice a day to the lower lid.
This is what the algorithm said.
I had not edited the photographs. I had not changed the lighting. I had not even kept any volunteer's second attempt over their first attempt. The algorithm was doing its job. The algorithm had simply changed its mind.
What three experts said when I sent them the four screenshots.
I sent the day-zero and day-twenty-eight filter screenshots to Dr. O'Connor, to the cosmetic chemist who had spoken to me off-record in February, and to Lukas in Berlin. I did not tell any of them what each other had said.
Dr. O'Connor wrote back the same afternoon. "The change in the verdict is consistent with what I would expect from sustained punicic acid exposure on lymphatic-stagnation skin combined with bakuchiol at concentration. The lower-lid hollow is responding to the humectant. The algorithm is reading reduced structural age signal because there is reduced structural age signal to read. The photographs are showing the cellular work that the formulation has done."
The cosmetic chemist wrote back the same evening. "I told you. The percentage on the front of the box is for the press release. This is what it looks like when somebody formulates to the cells instead of the campaign. I am ordering a jar tonight."
Lukas rang me from Berlin two days later. He had run a frame-by-frame structural comparison on the day-zero and day-twenty-eight images. He confirmed that the change in the algorithm's verdict was being driven by quantifiable structural change in the lower-lid region of each image, not by any lighting or angle artefact. The verdict drop was real. The algorithm was simply telling the truth in both directions.
The cream itself. The texture the volunteers applied twice a day for twenty-eight days. Pale, slightly satin, faintly pomegranate-scented.
What you can do with the information in this article.
This is the second piece of beauty journalism I have written in fourteen years that recommends a specific product without qualification. The first was about an SPF in 2018. I stand over both.
The single jar of Lift & Brighten Peptide Eye Cream is forty-four euro, including VAT and including Irish delivery on orders over forty euro. The jar is thirty millilitres. At the rate the four volunteers used it during the trial, which is twice a day on both eye areas, the jar lasts approximately ten weeks.
Gentle & Rose offer a sixty-day money-back guarantee on opened, used product. You return the jar at any state of usage within sixty days and they refund you in full. I asked them to confirm this in writing before I published this piece. They confirmed.
Other women I spoke to during the investigation.
In the months after my previous piece appeared, and then more recently during this investigation, I have spoken to dozens of Irish women who have either been using the product already or who started during the period I was reporting this story. I am including five of them here. The full transcripts are on file with my editor.
Questions I asked Gentle & Rose before publishing.
Why I am publishing this on a Wednesday morning in April.
I am publishing this because a piece of consumer software that nobody in the beauty industry asked to exist has accidentally exposed something the industry has been quietly profiting from for at least twenty years. The eye area is the part of the face strangers read first. The eye area is the part of the face strangers read most reliably. And the eye area is the part of the face the industry has been telling women, by omission, not to worry about.
I have spent fourteen years writing about wrinkles. I have produced one investigation about the eye area. This is, in my professional view, the most important piece of beauty journalism I have written in my career, and I am angry about how late I am to it.
The algorithm is not a kind witness. It is a neutral one. It does not care about your feelings, and it does not care about the beauty industry's margins. It cares only about what the eye area of a human face is structurally telling it about cumulative biological time. There is exactly one over-the-counter formulation in this country that, in my reporting, has been shown to change what the algorithm reads. It costs forty-four euro. It is linked below.
Caoimhe Sheridan, Dublin, 22 April 2026.